Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
July 19, 2024 2:35 PM 4 min read

Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims

by Michael Juliano
Follow

ArticleFeaturedTickersList12345!!!

DaVita Inc. (NYSE:DVA), a Colorado-based kidney dialysis provider, agreed to pay $34.5 million for allegedly paying kickbacks to a competitor for making referrals to DaVita Rx, a former subsidiary that provided pharmacy services for dialysis patients.

DaVita also allegedly paid kickbacks to nephrologists and vascular access physicians to get patient referrals to DaVita's dialysis centers, the U.S. Department of Justice (DOJ) said on Thursday.

The DOJ said DaVita violated the False Claims Act’s Anti-Kickback Statute, which prohibits providing any payments that are intended to induce referrals of patients or items or services covered by Medicare, Medicaid and other federally funded programs.

The U.S. alleged DaVita paid kickbacks to the competitor under the agreement that Davita Rx would serve as a "central fill pharmacy," or prescription fulfillment provider, for that competitor's Medicare patients' prescriptions.

In exchange, DaVita paid to acquire certain European dialysis clinics and agreed to extend a prior commitment to purchase dialysis products from the competitor, the DOJ said.

The U.S. further alleged DaVita provided management services to vascular access centers owned by physicians in a position to refer patients to DaVita's dialysis clinics. DaVita would not charge management fees to the physicians in exchange for referrals to DaVita's dialysis centers.

Finally, DaVita allegedly paid kickbacks to a large nephrology practice for referrals to DaVita's dialysis clinics. According to the DOJ, DaVita gave the practice a right of refusal to staff the medical director position at any new dialysis center that opened near the nephrology practice and paid the practice $50,000 for not staffing the medical director position for those clinics.  

Hospice Provider Gentiva Ordered To Pay $19.4M for Submitting False Claims

Gentiva Health Services, a Georgia-based hospice provider and successor to Kindred at Home, has agreed to pay $19.4 million for Kindred at Home allegedly knowingly submitting false claims and keeping overpayments for hospice services given to patients who were ineligible for hospice benefits under federal health care programs.

Gentiva's hospice operations include entities that previously operated Kindred at Home hospice locations under the names Avalon, Kindred, SouthernCare and SouthernCare New Beacon, the DOJ said.

A 2021 joint complaint the U.S. and Tennessee alleged that, from 2010 to February 2020, Kindred filed false claims for hospice services provided to Avalon hospice patients in Tennessee who were ineligible for the Medicare or Medicaid hospice benefit because they were not terminally ill.

Also Read: Boeing Gains Despite Prosecutors’ Push For Criminal Charges

The settlement also resolved allegations that Kindred improperly concealed or avoided Avalon's obligation to repay those hospice claims.

Certain Kindred, SouthernCare and SouthernCare New Beacon hospice locations also allegedly submitted false claims for hospice services provided to patients who were ineligible for hospice benefits. Those hospice facilities were Kindred locations in Rhode Island, Texas and Missouri; SouthernCare New Beacon's location in Alabama; and SouthernCare's locations in Alabama, Indiana and Ohio.

The settlement also resolves allegations that those Kindred, SouthernCare and SouthernCare New Beacon locations knowingly and improperly concealed or avoided obligations to repay the foregoing hospice claims, according to the DOJ.

SouthernCare New Beacon also allegedly violated the Anti-Kickback Statute by paying kickbacks to a consulting physician, between October 2016, and October 2022, to send hospice referrals of Medicare beneficiaries to its Gadsden, Alabama, location.

GPS Maker Hemisphere Pays $2.6M For Making False Claims To Paycheck Protection Program

Hemisphere GNSS (USA) Inc., a satellite global positioning system manufacturer in Arizona that was purchased by CNH Industrial N.V. (NYSE:CNH) in 2023, has agreed to pay $2.6 million for allegedly violating the False Claims Act by providing false information to apply for and receive forgiveness for a Paycheck Protection Program (PPP) loan.

Congress created the PPP in March 2020, as part of the Coronavirus Aid, Relief and Economic Security (CARES) Act, to provide emergency financial support to Americans suffering the economic effects caused by the pandemic.

In February 2021, Hemisphere applied for a second-round PPP loan and certified that it was eligible to receive the loan, though it was ineligible because it falsely certified that a Chinese company did not hold at least 20% interest in the company and a resident of China was not sitting on its board of directors.

For this reason, Hemisphere was not eligible for the second round PPP loan that it received and then sought and received forgiveness of the total loan amount.

Read Now:
• Apple May Soon Face Antitrust Lawsuit From Department of Jusice: Report

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
GovernmentRegulationsHealth CareLegalTop StoriesTechDepartment of JusticeFinancial Crime WeeklyStories That Matter
CNH Logo
CNHCNH Industrial NV
$12.69-%
Overview
DVA Logo
DVADaVita Inc
$149.97-%
CNH Logo
CNHCNH Industrial NV
$12.69-%
Overview
DVA Logo
DVADaVita Inc
$149.97-%
Comments
Loading...